Podcasts about Huntington

Travelers on the Kansas trail stopped at a lonely inn run by a family of Spiritualists — and the ones who sat in the seat nearest the curtain were never seen leaving it.

It's Theme Park Thursday! This week, Jen and Frank are playing Disney Resort Match Game! Each will pick a Disney resort for every month of the year to see how many times their picks actually line up. Grab some paper, a pen and play along! Tune in to see how many matches we score! *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

Send us Fan MailIn her memoir, Lady MacGyver, Michelle Huntington shares everything from ferry flights across oceans to surviving a lightning strike over Australia's Snowy Mountains, building an airline career after being told women couldn't be pilots, motherhood, breast cancer, and the mindset that carried her through it all. Our discussion explores those experiences, along with her writing process, her philosophy of "keep going until you can't," and even a friendly debate about the word aviatrix.But when we chatted, I hadn't finished the book yet. Without spoiling the ending, I'll simply say that the final chapters gave me an even deeper appreciation for Michelle's courage and reminded me that the barriers women face in aviation are far more recent, and far more persistent, than we'd like to believe.Lady MacGyver needs to be on every aviation company CEO's, COO's, and Human Resources Manager's reading list. Our community's culture still needs a lot of work.Did you know you can support your local independent bookshop and me by shopping through my Bookshop.org affiliate links on my website? If a book is available on Bookshop.org, you'll find a link to it on the book page. By shopping through the Literary Aviatrix website a small portion of the sale goes to support the content you love, at no additional cost to you. https://literaryaviatrix.com/shop-all-books/Thanks so much for listening! Stay up to date on book releases, author events, and Aviatrix Book Club discussion dates with the Literary Aviatrix Newsletter. Visit the Literary Aviatrix website to find over 600 books featuring women in aviation in all genres for all ages. Become a Literary Aviatrix Patron and help amplify the voices of women in aviation. Follow me on social media, join the book club, and find all of the things on the Literary Aviatrix linkt.ree. Blue skies, happy reading, and happy listening!-Liz Booker

In this explainer episode, we've asked Ella Davyson, Genomics Data Scientist, to explain the meaning of the term genomics. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you've got any questions, or have any other topics you'd like us to explain, let us know on podcast@genomicsengland.co.uk. You can download the transcript or read it below. [00:00:00] Florence: What is genomics? My name is Florence Cornish, and today I'm joined by Ella Davyson, who is a genomics data scientist here at Genomics England, and she is here to explain the topic in much more detail So, Ella, we obviously both work at Genomics England. This podcast is called Genomics 101, so I guess it's fitting that we have an episode dedicated to explaining the term 'genomics'. [00:00:26] But before we get into that, I think it would be good if you could first explain what we mean by the term 'genome'. [00:00:32] Ella: Thanks, Florence. The genome is, essentially you can think of it like a manual booklet, or instructions that the body uses in how to grow, survive, and function, and this is a manual that's in every single cell within our body, and it tells our cells exactly how to divide, how to survive. [00:00:54] For example, the genome in the pancreas, in pancreatic cells will tell those cells how to produce proteins such as insulin that we need to control our blood sugar. And also, the genome within our eye cells will tell the cells how to generate photoreceptors to enable us to see. So the genome is essentially like the ultimate guide that our body uses to tell it how to create everything that we need to survive going forwards. [00:01:25] Florence: So then, what do we mean by the term 'genomics'? [00:01:30] Ella: So, genomics is essentially the study of the entire human genome. So we study its structure and also how it functions, in terms of how is this instruction manual being read by the body, and how does that result in healthy human beings that we see today. [00:01:48] Florence: So when we're talking about studying DNA, lots of our listeners might have heard the term 'genetics', which kind of also refers to the study of DNA and genes, so it might be a little bit confusing. [00:01:58] So what's the difference between the two? What's the difference between genetics and genomics? [00:02:04] Ella: So genetics is specifically the study of genes in the genome, and genes are part of the instruction manual, that specifically tell the body to produce a certain thing. So, in our insulin example, there is an INS gene, so, which is the gene in the genome or the instruction manual that specifically tells the cells to make insulin and to produce this product. [00:02:30] There are many different genes in our genome, and genetics is the study of all of these. In contrast, genomics is the study of the entire instruction manual altogether, so that includes all of the genes in genetics and also everything else in the manual. So, genetics is limited to the study of these parts of the manual that clearly encode certain proteins or products such as insulin. Genomics is the study of everything all at once, everything under the bathroom sink. So yeah, the confusion I think can arise a lot because historically when we first started looking at DNA and researching genetics, we didn't have the technology to look at the whole genome all at once, and with older sequencing technologies we would focus on particular genes that we knew important for certain diseases. [00:03:19] So in diabetes, for example, they would instead specifically look at the insulin gene and see how does this influence diabetes, rather than looking at the entire instruction manual at once. Nowadays, we do have that technology, and that is what we do here at Genomics England, just use that to look at the entire genome rather than specific subsets of the genome, so specific genes. [00:03:45] We can look at everything in its entirety. So, you can kind of think of genomics as a much broader, more complete study of genetics. [00:03:56] Florence: So speaking of genomic testing, I don't know if you saw, but in the government's 10-year Health Plan that they published last year, they predicted that genomics could play a role in up to 50% of healthcare interactions. [00:04:08] Could you tell me a bit about why genomics is important in healthcare? [00:04:12] Ella: So that's a really exciting point, and I think one that we should be all striving towards. So, genomics can play a role in healthcare in so many different ways. I think before going into each of them, it's kind of maybe important just to illustrate that our genomes between two, two people are 99.9% the same. [00:04:38] So we're both humans. We are both the same species. There is 0.1% difference between two people's genomes, and those differences underlie all the uniqueness that makes a person a unique individual. [00:04:54] So personality, appearance and also risk to different health and disease outcomes. So that is where the role of genomics can come in, is to understand how the differences between people and their genetic makeup can influence maybe their risk for being more predisposed to developing a condition. Conditions such as Cystic Fibrosis or Huntington's disease that are specifically caused by genetic variants or mutations in genes that directly cause the condition. So it's a bit more maybe obvious, if you like, about how studying genetics in those, in those conditions can directly inform on how they arise, potential ways that we can better treat them. [00:05:52] So another way that genomics can be used in healthcare is through screening. So this is being piloted at the moment in the Generation Study by Genomics England which is applying whole genome sequencing to newborn babies to look for a range of conditions which are caused by genetic changes, all of which are treatable. [00:06:13] But importantly, screening will enable clinicians and families to know about these conditions much earlier and start life-changing treatment much, much sooner. So this is kind of already beginning to be, I think it will be showcased with this study in the next couple of years and the power of this in healthcare, I think can't really be overestimated. [00:06:40] Florence: And finally, just to finish off, is there anything coming up in the field of genomics that you're especially excited about? [00:06:48] Ella: There are loads of different things that I'm excited about in the field of genomics. I think probably maybe one that's most kind of relevant to clinical care is the possibility of doing more personalised medicine with treatments. [00:07:05] Often, at the moment, we majority have kind of one treatment for all when treating certain conditions, and sometimes these treatments aren't tolerated well by some people, and also some of these treatments just don't work well in some people as well. Sometimes there's a clear reason for these things, but more often than not, it's not entirely clear why some people might benefit more for some treatments or some people don't respond or don't react well to some treatments as well. [00:07:35] And understanding more, so there's a whole field about how genomics interacts with drugs and medicines, which is called pharmacogenomics, and its aim is to understand which medicine might be most effective or well-tolerated in certain people based on their genetics. And I think that will be kind of life-changing as well for some people, who are suffering from diseases where the medication is either not effective enough or is also affecting their quality of life. [00:08:10] Florence: Mm-hmm. [00:08:10] Ella: Because that is a whole other part of it as well is that sometimes these treatments for certain conditions are really hard to tolerate. [00:08:19] Other things that I'm excited about are just the technologies that are coming out at the moment mean that we can measure and understand a whole lot more about genomics than we used to be. So now we can say this gene is influencing this disease, but sometimes, you know, it's more complicated, and we now have the technology to measure all sorts of different things, so how our environment can influence our genes and how our genes react with each other. [00:08:57] So we're just getting, we're getting able to look at more and more, and I think we'll expand our understanding in a lot of conditions that unfortunately aren't very simple. [00:09:12] Florence: Well, I think we'll finish there. Thank you so much, Ella, for coming on and for taking the time to explain genomics to us. [00:09:18] Ella: Thank you, Florence. Thanks so much for inviting me, and it was a pleasure to be on the podcast today. [00:09:23] Florence: If you want to hear more explainer episodes like this, you can find them on our website at www.genomicsengland.co.uk or wherever you get your podcasts. Thank you for listening.

This week on the Long Island Tea Podcast, we're celebrating one of Long Island's most beautiful summer traditions with a visit to Lavender By the Bay on the North Fork! Surrounded by thousands of blooming lavender plants, Sharon and Stacy sit down with co-owner Chanan Rozenbaum to learn how this family-owned farm has become one of Long Island's most iconic summer destinations.Sharon and Stacy also catch us up on the grand reopening of the Tesla Science Center at Wardenclyffe, an elegant afternoon at OHEKA Castle's Formal Garden Party, and a special family milestone as Sharon takes her daughter to her very first concert. Plus, they're sharing hometown success stories, hidden gems, wildlife encounters, and plenty of ways to make the most of summer on Long Island.#ShowUsYourLongIslanderThis week's spotlight features Long Island native Carolyn Miller, who is returning home to headline a free concert at Heckscher Park in Huntington during the Huntington Summer Arts Festival.Show us YOUR Long Islander by sending us a DM or emailing spillthetea@discoverlongisland.com.#TasteOfLongIslandPeak lavender season has arrived at Lavender By the Bay, and this week we're joined by co-owner Chanan Rozenbaum to learn how the beloved North Fork destination has become one of Long Island's favorite summer traditions.From the breathtaking lavender fields to handcrafted products in the farm shop, Chanan shares the story behind the farm, what makes visiting during peak bloom so special, and why families return year after year to experience the beauty of lavender season.#HiddenGemsUncorkedThis week's hidden gem is 67 Steps Beach in Greenport.#LongIslandLifeThis week we're discussing:-The return of the 31st Annual Stony Brook Film Festival, bringing world premieres, acclaimed independent films, and filmmaker Q&A sessions to Long Island.-Long Island native Matt Seelinger achieving his lifelong dream by making his Major League Baseball debut with the New York Mets-A free community nature walk at Indian Island County Park in Riverhead, offering families the opportunity to explore Long Island's incredible wildlife and natural beauty.-Discover Long Island's newest summer travel blog, highlighting some of the best destinations, hidden gems, and coastal escapes to explore this season.#WildThingsOfTheWeekThis week we're sharing two unforgettable wildlife stories:-Apollo, a 13-year-old Shih Tzu, who was miraculously reunited with his Florida family after somehow traveling more than 1,000 miles and ending up at a Long Island animal shelter.-An endangered fin whale making a rare appearance off the coast of Hampton Bays, giving local drone photographer Virginia Fitzgerald an incredible once-in-a-lifetime encounter with the second-largest animal on Earth.#ThisWeekendOnLongIslandFriday, July 1731st Annual Stony Brook Film Festival – Staller Center for the Arts | Stony Brook (All Weekend)Adventureland Drone Light Show – Adventureland | East FarmingdaleWild Child: A Tribute to The Doors – The Paramount | HuntingtonBeautiful: The Carole King Musical – The Argyle Theatre | Babylon (All Weekend)Hamptons Greek Festival – Dormition of the Virgin Mary Greek Orthodox Church | Southampton (All Weekend)Saturday, July 18Sunset Music: Dan Bailey Tribe – Wölffer Wine Stand | SagaponackLive Music with Katt Rardi – Bridge Lane Wine | MattituckHow to Make a Comic Book Workshop – Gallery North | SetauketMattituck Summer Concert Series – Veterans Memorial Park | MattituckSunday, July 19Antique Car Show – Sagtikos Manor | Bay ShoreFIFA World Cup Final Watch Party – Patchogue-Medford Library | PatchogueBroadway Under the Stars – Celebrate Saint James Summer Concert Series | St. JamesFor more events happening across Long Island, visit discoverlongisland.com/events.#CelebriTEALong Island native Melissa Joan Hart and her mother, Paula Hart, will receive the inaugural Vanguard Legacy Award during the first-ever Sayville International Film Festival this August. Hosted on Acast. See acast.com/privacy for more information.

IN CLEAR FOCUS: Guest Anne Huntington Sharma, CEO of Huntington Learning Center, explores brand stewardship in an age of AI-led disruption. Discover how a nearly 50-year-old heritage brand is reinventing its identity to connect with millennial parents while preserving accumulated trust. Learn about balancing franchise collaboration with compliance, integrating artificial intelligence tools like agentic tutors, and leveraging both physical and digital experiences to drive results.

Today on MetroNews This Morning: --A marathon city council meeting in Huntington results in agreement to purchase the conteroversial Flock Camera and Safety system for the city--WVU Health Systems and the U.S. Attorney reach a settlement over the mishandling of controlled substances--A federal judge tosses the Department of Justice lawsuit against West Virginia over voter information--In Sports: Marshall is ranked 3rd in the Sunbelt preseason program 

Curtis is weighing whether to accept a plea deal or risk ten years in prison by fighting the charges over a punch that sent Isaiah falling into a table. Cassius turns out to be alive after all. Britt's Huntington's diagnosis turns out to have never been real. Valentin walks free with a full pardon and heads straight back to Carly and Charlotte. And Anna finally comes home to find out exactly how much she missed. We also cover Chase finding out who set Willow up, Molly's impossible choice on whether to prosecute Sidwell, and Liz working out a theory about Willow's house. Plus this week's Port Charles Pipeline, Reality Check, and a preview of Thursday's Port Charles 411 on Valentin. Find us at GeneralHospitalPodcast.com. New episodes every Monday and Thursday. Learn more about your ad choices. Visit megaphone.fm/adchoices

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of transformative updates and strategic shifts within the industry, reflecting both remarkable progress and inherent challenges. Sanofi's recent achievement marks a significant milestone in oncology with the FDA approval of Sarclisa Escena (isatuximab) as the first on-body injector for multiple myeloma treatment. This monoclonal antibody, targeting CD38, offers a novel subcutaneous delivery method, simplifying administration and potentially enhancing patient compliance by reducing the need for frequent clinic visits. This aligns with the industry's ongoing shift towards patient-friendly drug delivery systems, emphasizing convenience without compromising efficacy. In another promising development, GSK and Hansoh Pharmaceutical have reported positive results from their Phase 3 trial evaluating risvutatug rezetecan for small cell lung cancer. This antibody-drug conjugate, targeting B7-H3, has shown potential when combined with chemotherapy to extend patient survival. Given the aggressive nature of small cell lung cancer and limited treatment options, these findings underscore the potential of targeted therapies to improve clinical outcomes significantly. Forte Biosciences' FB102 also takes a spotlight in clinical advancements. In its Phase 1b trial for vitiligo, FB102 demonstrated a 45.8% placebo-adjusted benefit. This monoclonal antibody works by modulating immune responses through the IL-15 pathway via CD122, offering new hope for patients with this challenging autoimmune condition. On the regulatory front, ARPA-H's commitment of up to $160 million towards developing personalized genetic medicines for rare diseases is noteworthy. This investment is set to accelerate innovations in gene therapy and personalized medicine platforms. Such advancements promise to revolutionize pediatric care and extend beyond by tailoring treatments to individual genetic profiles, enhancing efficacy while minimizing adverse effects. Strategic collaborations continue to reshape the industry landscape. Rani Therapeutics' partnership with PegBio aims at advancing oral delivery systems for obesity and metabolic diseases. Similarly, Simcere Pharmaceutical's collaboration with Schrödinger leverages AI-driven drug discovery efforts. These alliances highlight an increased reliance on computational platforms to streamline therapeutic development processes. From a financial perspective, Mesoblast Limited reports substantial revenue from its cell therapy product Ryoncil, signaling strong commercial viability for cell-based treatments targeting rare diseases. Additionally, Cue Biopharma's successful $50 million fundraising underscores investor confidence in advancing therapies for immunological disorders. However, not all news is positive. Roche has decided to halt two programs targeting Huntington's disease due to inadequate efficacy and safety concerns. This decision reflects the complexities involved in developing effective treatments for neurological disorders—a field fraught with scientific challenges yet rich with potential rewards. In market dynamics, McKinsey's report advocates for a structural redesign of biopharmaceutical R&D to fully leverage AI's capabilities. This recommendation resonates with current industry trends focusing on strategic innovation to maximize efficiency and discovery potential. The FDA's third rejection of Hengrui Pharma and Elevar Therapeutics' combination therapy for liver cancer underscores the rigorous scrutiny such treatments face despite their promise in addressing complex cancers. In contrast, BioNTech's preparation to launch its HER2 antibody-drug conjugate (ADC) signifies its strategic pivot back towards oncology after mRNA vaccine successes. Bayer's decision to sell a minority stake in its contraceptives business demonstrates how companies are strategically realigning portfolios to focus on core areas while securing funding for innovation. This move reflects broader trends within pharma as companies navigate financial landscapes to support long-term research goals. Amid these developments, regulatory environments continue evolving. NICE's stance against future Lumakras reimbursement in the UK highlights ongoing challenges in balancing cost-effectiveness with access to innovative therapies. Meanwhile, ARPA-H's significant funding allocation signals robust governmental support for advancing precision medicine within genetic therapies. In conclusion, today's updates reveal an industry characterized by a relentless pursuit of innovation amidst complex regulatory landscapes. As companies navigate these dynamics through strategic collaborations and scientific breakthroughs, their efforts hold promise for enhancing patient care across diverse therapeutic areas globally. Stay tuned as we continue to track these exciting developments shaping the future of pharmaceuticals and biotechnology. Thank you for tuning into Pharma Daily—your go-to source for up-to-date insights from the world of pharmaceuticals and biotechnology.Support the show

We'll break down what the latest heat warnings mean as temperatures rise. The countdown is on as a stinky, rare flower gets ready to bloom in the San Gabriel Valley. Plus food and culture writer Gab Chabrán shares how you can drink like a Spaniard without leaving SoCal. Support The L.A. Report by donating at LAist.com/join and by visiting https://laist.comSupport the show: https://laist.com

I was able to see Disterbenz (the moniker of Gabrielle Sterbenz) perform live a few years back when she opened for Wheatus and was majorly impressed.  She has a powerful voice and a performance that includes looping of her vocals and guitar that really impresses.  And the songwriting is stellar - mostly Americana, but really a sound all her own.You may already know that she is a member of Wheatus as a backing vocalist.  But her catalog of solo music is vastly different and worthy of your ears.We'll hear all about Gabrielle's journey and inspirations as well as her upcoming brand new music about to be released - we get an exclusive early listen to share it with you on the show!We'll also share a few tracks from her catalog so you can get a full Disterbenz experience.  Don't miss it!DisterbenzAmericana singer-songwriter, Gabrielle Sterbenz, has performed her music in 49 US States, Canada, the UK and EU, and AustraliaWhile writing and recording her own music, she made ends meet as a backing vocalist, with stints on The Tonight Show, Late Night with Seth Meyers, Late Night with Jimmy Fallon, as a backing vocalist for Robbie Dupree (Steal Away), and as a sidewoman for Mike Doughty (Soul Coughing). Gabrielle is currently releasing songs from her second studio album, “Icky Guy,” which she made with producer, Philip A. Jimenez, in Huntington, NY, the very town where she got her start singing.Text us your thoughts on this episode, and who should be OUR #NextFavBand...As always, our hope is to bring you "your next favorite band".  If you tuned in today because you already knew this musician - thank you very much!  We hope that you enjoyed it and would consider following us and subscribing so we can bring you your #nextfavband in the future.  And check out nextfavband.com for our entire catalog of interviews!If you have a recommendation on who you think OUR next favorite band should be, hit us up on social media (@nextfavband everywhere) or send us an email at nextfavband@stereophiliastudio.com.Thank you to Carver Commodore, argonaut&wasp, and Blair Crimmins for allowing us to use their music in the show open and close.  It makes everything sound so much better!Let's catch a live show together soon!#nextfavband #livemusic #music #musicinterview #musician  #singer  #guitar  #song  #newmusic  #explorepage  #instamusic #bestmusic #musicismylife #musicindustry #musiclife #songwriter #musiclover #musicfestival 

This week on Theme Park Thursday, Frank and Jen celebrate a BIG milestone: Disney's BoardWalk Inn is turning 30! They take a stroll down memory lane through three decades of this beloved Epcot-area resort and dive into the upcoming changes headed to the BoardWalk. *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

In this episode of Personally Speaking, Msgr. Jim Lisante is joined by Msgr. Peter Vaccari. Msgr. Vaccari is a priest of the Roman Catholic Diocese of Brooklyn. He is president of the “Catholic Near East Welfare Association” and the president of its operating agency in the Middle East, the “Pontifical Mission for Palestine”. Msgr. Vaccari was the rector and president of St. Joseph's Seminary in Yonkers, New York, the seminary of the Archdiocese of New York and the dioceses of Brooklyn and Rockville Centre.  Before serving at St. Joseph's, he was rector of the Seminary of the Immaculate Conception in Huntington, Long Island. Msgr. Vaccari talks about his life, his vocation journey, how he has served the church of greater New York in a variety of capacities, and his insight into the humanitarian crisis facing vulnerable communities across the Middle East, Northeast Africa, India and Eastern Europe.Support the show

Dr. Jess Peatross trained in conventional medicine and worked as a hospitalist before she started questioning why so many chronically ill patients kept getting worse inside the healthcare system she trusted. Her perspective carries weight because she spent years following every protocol exactly as taught before walking away from hospital medicine entirely.Raised in Huntington, West Virginia during the opioid crisis, she entered medicine believing the system existed to heal people. Instead, she found hospitals driven by billing codes, liability management, and pharmaceutical dependence while patients with chronic illness, autoimmune disease, mold exposure, and chronic pain cycled endlessly through appointments and prescriptions.Dr. Peatross explains what pushed her toward functional medicine, cannabis therapy, and prevention focused care after watching patients improve only after leaving conventional treatment pipelines behind. The conversation tackles physician burnout, chronic illness stigma, healthcare incentives, and the growing collapse of trust between patients and institutions.The discussion also moves into supplements, environmental toxins, ultra processed food, and the uncomfortable economics behind keeping people permanently sick but continuously billable. Dr. Peatross describes the professional backlash that comes with challenging medical orthodoxy while Matthew connects her experience to the broader erosion of public trust across American healthcare.Together they unpack what happens when patients stop believing the system can help them and start searching elsewhere for answers.RELATED LINKSDr. Jess PeatrossInstagramMarshall UniversityBrave New WeedFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week on the Long Island Tea Podcast, we're keeping Long Island's LI250 celebrations going with a special on-location episode filmed at the historic William Floyd Estate in Mastic Beach! As the home of William Floyd, one of the few New Yorkers to sign the Declaration of Independence, this remarkable landmark offers the perfect backdrop to continue celebrating Long Island's vital role in America's founding. Of course, William Floyd was a proud Long Islander!Sharon and Stacy also catch listeners up on everything happening at Discover Long Island, including the organization's successful quarterly immersion in Huntington, where the leadership team shared an inside look at the year-round work that drives Long Island's visitor economy. They also recap a fun staff outing at Adventureland, where the team got a firsthand look at the exciting new attractions and enhancements guests can experience this season.#ShowUsYourLongIslanderThis week's spotlight features Long Island photographer Xiomaro (See-Oh-Mah-Ro), whose remarkable exhibition, *The Seat of Action* at the Long Island Museum in Stony Brook, is helping visitors experience history in an entirely new way. His striking photographs of the William Floyd Estate offer a rare and deeply personal look at the life of William Floyd, the only Long Island signer of the Declaration of Independence.Show us YOUR Long Islander by sending us a DM or emailing [spillthetea@discoverlongisland.com](mailto:spillthetea@discoverlongisland.com).#LongIslandRevolutionaryRootsThis week, we sit down with Fire Island National Seashore Superintendent Alexcy Romero from the National Park Service for a fascinating conversation about the William Floyd Estate. Alexcy shares what makes this historic property so special, why preserving William Floyd's legacy is so important, and what it means to lead the dedicated team responsible for caring for one of Long Island's most significant Revolutionary-era landmarks. It's an inspiring look behind the scenes at the people working every day to preserve Long Island's place in American history.Plan your visit: https://www.nps.gov/fiis/planyourvisit/williamfloydestate.htm#LongIslandLifeThis week we're discussing:-A major naturalization ceremony in Central Islip, where 86 people from 37 countries officially became United States citizens.-The East End Seaport Museum's restoration project preserving the iconic Bug Light lighthouse on the North Fork.-More than $10 million in new state funding expanding childcare opportunities for Long Island families.-Two 12-year-old entrepreneurs from Islandia turning a pandemic hobby into a successful baking business.-Some of the best ways to enjoy Long Island's waterfront this summer, from sailing adventures and fishing charters to scenic cruises.#ThisWeekendOnLongIslandFriday, July 10Dirty Deeds: The AC/DC Experience – Suffolk TheaterThe Wedding Singer – John W. Engeman TheaterVintage Vinyl: Paint & Pour Workshop – Long Island Museum of American Art, History & CarriagesBay Shore Farmers MarketNeon Nights – Splish Splash Water ParkSaturday, July 11Nikola Tesla Expo – Tesla Science Center at WardenclyffeShelter Island Fireworks Cruise – Sail SelinaNugent Carriage House Thrift Shop – Southampton History MuseumSunday, July 12Sea Glass Festival – Whaling Museum & Education Center of Cold Spring HarborHuntington Lighthouse ToursFor more events happening across Long Island, visit discoverlongisland.com/events.Call us at 877-386-6654 x400 and tell us "How YOU Doin'?" We'd love to hear from you, and don't forget to leave us a review!Connect With UsInstagram: https://www.instagram.com/longislandteapodcastTikTok: https://www.tiktok.com/@longislandteapodcastYouTube: https://www.youtube.com/@DiscoverLongIslandFacebook: https://www.facebook.com/LongIslandTeaPodcastX: https://x.com/liteapodcastWebsite: https://www.discoverlongisland.com/long-island-tea-podcast/Events: https://www.discoverlongisland.com/events/ Hosted on Acast. See acast.com/privacy for more information.

Huntington's favorite son first made his name as a star at Douglass High School, and then went just a few blocks away to Marshall University. Being the first Black player at any West Virginia college, he shattered ceilings as well as records. First drafted into the NBA by the Syracuse Nationals, he made his name legendary when the team transferred to Philadelphia and became the Seventy-Sixers, where many of his records still stand in franchise history, and he is still known as one of the best players the league has produced.  

Dr. Sarah Camargos is joined by Dr. Rajeev Kumar to explore early research on targeting neuroinflammation in Huntington's disease. Dr. Kumar delves into the intricacies of the complement cascade, highlighting the pivotal role of C1q as the recognition molecule at the top of this immune system chain reaction and how ANX005 aims to prevent the initiation of the cascade. He further discusses the implications of biomarker advancements and safety protocols in moving towards more effective treatments for Huntington's disease. Read the article. Journal CME is available until June 30, 2027.

This week on Theme Park Thursday, we're sitting down with Dillo's Diz Resort guest Ryan for a full trip report covering two very different (but equally magical) sides of Disney travel: a stay at Disney's Polynesian Village Resort and a voyage aboard the Disney Wish! *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a wave of exciting advancements and strategic movements shaping the landscape of this ever-evolving industry. Starting with a significant breakthrough in cell therapy, the FDA has granted approval to Orca Bio's Tregzi, a novel treatment aimed at preventing graft-versus-host disease (GVHD) in blood cancer patients undergoing allogeneic transplants. This approval emphasizes the potential of regulatory T cells in mitigating the severe complications that often accompany such transplants. The success of Tregzi not only marks a pivotal moment for cell therapy but also heralds a new era in transplant medicine where cellular therapies can significantly improve patient outcomes by reducing GVHD incidence. In other strategic moves, Ipsen's acquisition of Memo Therapeutics for up to $796 million highlights the industry's focus on addressing unmet needs in transplant medicine. Memo's work on monoclonal antibodies targeting the BK virus—a significant threat to kidney transplant patients—reflects a growing trend towards personalized medicine and targeted biologics. This acquisition is poised to bring much-needed therapeutic interventions to market, underscoring the sector's commitment to innovative solutions. Meanwhile, Anthropic is making waves with the introduction of Claude Science AI Workbench, accompanied by an internal drug discovery program aimed at neglected diseases. This initiative underscores the transformative role of artificial intelligence in drug discovery, particularly in areas previously overlooked due to limited commercial incentives. By accelerating the identification and development of novel therapeutics, AI-driven platforms promise breakthroughs in treating rare and neglected diseases. In clinical trial news, Abivax has reported promising Phase 3 safety data for obefazimod, a miR-124 enhancer targeting ulcerative colitis. By alleviating previous cancer-related concerns, obefazimod stands out as a potential small molecule oral therapy for autoimmune conditions. This advancement demonstrates ongoing innovation in small molecule therapeutics designed to modulate immune responses, expanding treatment options for ulcerative colitis patients. On the financial front, several companies are bolstering their pipelines through significant funding efforts. Alvotech has secured a $75 million term loan to enhance its biosimilar pipeline, reflecting the increasing importance of cost-effective biologic alternatives. AB Science has raised approximately $2.62 million focusing on oncology and rare diseases like acute myeloid leukemia (AML) and amyotrophic lateral sclerosis (ALS). Additionally, Flare Therapeutics' $85 million Series C round emphasizes precision medicine approaches targeting transcription factors, illustrating the industry's dedication to precision medicine. Regulatory landscapes are also shifting with Sarepta Therapeutics' FDA acceptance for full approval bids on Amondys 45 and Vyondys 53 despite confirmatory trial challenges. These therapies leverage exon skipping technology for Duchenne muscular dystrophy treatment, highlighting the intricate balance between accelerated approvals and robust clinical evidence requirements. In mergers and acquisitions news, Kimball Electronics' acquisition of Helvoet Polymer Technologies expands their drug delivery systems capabilities across Europe and India. This strategic alignment reflects broader industry trends towards integrated service offerings and global expansion efforts. Regulatory challenges continue with leadership changes at the FDA as Vijay Kumar steps down amid ongoing turbulence within gene and cell therapy sectors. Additionally, Angitia Biopharmaceuticals' termination of its Phase 3 trial for its BMP-6 candidate illustrates inherent risks and strategic pivots often necessary in drug development. Turning our focus globally, China's approval of its first CAR-T therapy for solid tumors signals a pivotal moment in oncology. This milestone could spur similar advancements worldwide, particularly drawing interest on when such treatments might receive approval in other regions like the United States. Moderna's expansion into in vivo CAR-T therapies for autoimmune diseases further marks a strategic divergence from traditional approaches, aiming to create off-the-shelf solutions that redefine treatment paradigms. Gene therapy continues to gain traction as Uniqure navigates regulatory reversals from the FDA regarding its Huntington's disease gene therapy filing for accelerated approval. This development hints at a broader shift within regulatory bodies towards fostering innovation in rare disease treatments under new leadership directives. Industry-wide trends also reveal a notable shift towards automation in cell therapy production led by companies like Cellares and Ori. This reflects growing demands for scalable manufacturing processes that enhance production capabilities while reducing costs. Overall, these developments illustrate a dynamic landscape where scientific innovations, strategic partnerships, regulatory adjustments, and technological integrations drive progress across various medical fields. As these sectors evolve, they hold vast potential for transforming patient care through groundbreaking therapeutic options and improved healthcare delivery systems worldwide.Support the show

To open the episode, Erica Marini, PharmD, discussed a roundup of FDA and research updates in neurology. She covered the shifting accelerated-approval pathway for AMT-130 (uniQure), a gene therapy for Huntington disease, and a similar back-and-forth for a Hunter syndrome gene therapy. She also noted an expanded indication for olezarsen (Tryngolza; Ionis Pharmaceuticals) in severe hypertriglyceridemia, a UK study linking hypotension to Alzheimer risk, and data suggesting shingles vaccination may lower dementia risk in Medicare beneficiaries. From the American Headache Society meeting, she highlighted phase 2b data on the TRPM8 agonist elismotrep (Kallyope), and the anti-PACAP antibody bocunebart (Lundbeck) for migraine, along with retrospective findings tying CGRP monoclonal antibodies to increased fracture risk and higher odds of spontaneous abortion in early pregnancy.The core interview featured Adrian Wong, PharmD, MPH, BCCCP; and Cayley Krkljes, PharmD, BCPS, of Beth Israel Deaconess Medical Center who discussed a systematic review published in Pharmacotherapy of clinically significant drug-drug interactions with phenobarbital and primidone. Wong and Krkljes described growing use of phenobarbital for alcohol withdrawal and note that health care professionals often underappreciate its interaction potential despite it being a well-known enzyme inducer. Key findings included an induction onset of 24 hours to 30 days and an offset of 2 to 8 weeks, findings that carry particular weight for transitions of care since inpatient dosing effects can persist well after discharge. The most clinically impactful interactions involved anticoagulants (warfarin and direct oral anticoagulants [DOACs]), methadone, and immunosuppressants, with approximately 85% of reviewed studies reporting some outcome impact. They also pushed back on recent social media claims that phenobarbital-DOAC interactions are not clinically relevant, pointing out methodological limitations in the studies behind that claim.The conversation moved into practical risk stratification: The guests described considering a patient's individual risk factors—such as recent thrombosis, transplant status, or opioid use disorder treatment with methadone or buprenorphine—before choosing phenobarbital over benzodiazepines for alcohol withdrawal. They outlined next steps for research, including studying real-world outcomes in high-risk medication combinations and surveying health care professional awareness of these interactions to identify education gaps. The episode closed with career advice for pharmacists interested in research—start small, find mentors, and leverage institutional resources.Key Takeaways: Phenobarbital's interaction risk is widely underrecognized. Despite growing use for alcohol withdrawal, phenobarbital's enzyme-inducing effects can persist for weeks after the last dose (onset 24 hours to 30 days; offset 2 to 8 weeks), making transitions of care a critical window for catching interactions—especially with anticoagulants, methadone, and immunosuppressants, which accounted for the most clinically impactful outcomes in the review. Not all "reassuring" data holds up under scrutiny. Wong and Krkljes challenged circulating social media claims that phenobarbital-DOAC interactions aren't clinically relevant, noting the studies behind those claims had methodological limitations, emphasizing the importance of evaluating primary literature rather than secondhand interpretations. Risk stratification should guide phenobarbital use. Individual patient factors (eg, recent thrombosis, transplant status, or opioid use disorder treatment with methadone or buprenorphine) should inform whether phenobarbital or a benzodiazepine is the safer choice for alcohol withdrawal management.

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he covers today's top stories shaping America and the world. In this Listener Q&A episode of The Wright Report, Bryan breaks down the Supreme Court's 6-to-3 ruling striking down Trump's birthright citizenship executive order, walking through Justice Thomas's sweeping dissent, Justice Kavanaugh's narrow path forward, and a full menu of options from new legislation to a Convention of States to what Bryan calls the Bukele Options. Bryan then turns to the bigger picture, laying out a blunt assessment of what a future Democrat presidency means for open borders, deportations, and the survival of the Republic, and why he says the time to make a plan is right now, not in two or ten years. Listener questions drive the rest of the episode, covering the Supreme Court's transgender sports ruling, the Communist Control Act of 1954, how conservatives can get into local races despite imperfect pasts, and whether young men can be the generation that turns the tide against Marxism in America. Plus, good news for rural America as Trump invests $500M to keep small meatpackers competitive, a South Dakota storm that took down 20 wind turbines exposes the fragility of green energy, and German researchers announce a promising compound that may slow the progression of Huntington's Disease. "And you shall know the truth, and the truth shall make you free." - John 8:32   Keywords: Bryan Dean Wright, The Wright Report, birthright citizenship, 14th Amendment, Supreme Court ruling, Justice Thomas dissent, Justice Kavanaugh, Convention of States, Bukele Options, filibuster, SAVE America Act, AOC 2028, Communist Democrats, transgender sports ruling, gender dysphoria, Communist Control Act 1954, DSA Marxists, local elections conservatives, green energy wind turbines South Dakota, solar panels inverters China, Trump meatpackers $500M, small slaughterhouses rural America, Huntington's Disease treatment, AN LE 138b compound, Wednesday Q&A, listener questions

This week on the Long Island Tea Podcast, it's a milestone episode as we kick off Long Island's LI250 celebrations while celebrating 250 episodes of the Long Island Tea Podcast! Stacy and Sharon reflect on an exciting week, including recording a special on-location episode at Twisted Cow Distillery, announcing Sharon's new role stepping in as President & CEO of Discover Long Island, and looking ahead to the next chapter for both the organization and the podcast!They also dive into some of the stories shaping summer across Long Island, from the region's growing craft beverage scene and Revolutionary history to fireworks, live music, local food, and the people and places that make Long Island such a special destination.#ShowUsYourLongIslanderThis week's spotlight features Don Ryan, who spent more than 60 years mentoring young athletes through basketball while emphasizing education, character, and community. His influence reached generations of players, including Julius Erving, Ken Chenault, and Steve Mills, and his legacy continues to inspire through the book When Basketball Was a Game.Show us YOUR Long Islander by sending us a DM or emailing spillthetea@discoverlongisland.com.#LongIslandRevolutionaryRootsThis week we're spotlighting the Northport Historical Society & Museum, a featured stop on the Suffolk 250 Passport. Housed in the historic Carnegie Library, the museum explores Northport's maritime heritage, local history, and the people who helped shape this North Shore community.#LongIslandLifeThis week we're discussing:-Our special on-location episode from Twisted Cow Distillery and its commemorative America 250 bourbon.-Forbes' spotlight on Bedell Cellars and Long Island Wine Country.-The viral Trader Joe's mini tote craze across Long Island.-Fireworks season, Freedom Fest, and LI250 celebrations.-Free outdoor concerts happening across Suffolk County this summer.-Mann's Homemade Ice Cream's floating ice cream boat serving the South Shore.#ChariTEAThis week's ChariTEA honors Coach Chris Polhemus of Smithtown, who celebrated his retirement after 40 years of teaching by walking 88 miles from Commack to Montauk, raising more than $12,000 for United Cerebral Palsy of Long Island.#ThisWeekendOnLongIslandFriday, July 3Freedom Fest – Catholic Health Amphitheater at Bald HillLong Island History HuntAnnual July 3rd Celebration – AmityvilleHalsey House GalaLong Island Ducks Fireworks WeekendSaturday, July 4Riverhead America 250 Parade & FireworksNeon Nights – Splish Splash Water ParkHuntington Pet ContestSunday, July 5Port Jefferson 250 Block PartyFor more events happening across Long Island, visit discoverlongisland.com/events.#CelebriTEAThis week we're spotlighting Long Island native Landry Shamet returning home after helping the Knicks win the NBA Championship, along with Snooki's upcoming appearances in Huntington and Smithtown. We also celebrate Long Island's LI250 festivities with a Billy Joel tribute concert at Fireman's Park in Cold Spring Harbor.Connect With UsInstagram: https://www.instagram.com/longislandteapodcastTikTok: https://www.tiktok.com/@longislandteapodcastYouTube: https://www.youtube.com/@DiscoverLongIslandFacebook: https://www.facebook.com/LongIslandTeaPodcastX: https://x.com/liteapodcastWebsite: https://www.discoverlongisland.com/long-island-tea-podcast/Events: https://www.discoverlongisland.com/events/Email: spillthetea@discoverlongisland.comShop: https://shop.discoverlongisland.com/ Hosted on Acast. See acast.com/privacy for more information.

Click to Subscribe: https://bit.ly/Youtube-Subscribe-SoapDirt General Hospital July sweeps are predicted to be packed with intense drama and unexpected twists. Valentin Cassadine (James Patrick Stuart) is expected to make a heroic return while Jason Morgan (Steve Burton) returns to Port Charles to scold a loved one for good reason.  GH July sweeps predictions suggest the narrative sees a dangerous showdown between Sonny Corinthos (Maurice Benard) and Sidwell, potentially causing collateral damage and the death of Justine. Britt Westbourne (Kelly Thiebaud) is anticipated to return with Lucas Jones (Van Hansis) revealing she doesn't have Huntington's disease. Lucas and Joe Fitzpatrick (Jonathan Bennett) might embark on a romantic journey while Charlotte Cassadine (Scarlett Fernandez) is expected to reunite with her father, Valentin, and move in with him and Carly Corinthos (Laura Wright). July sweeps predictions for General Hospital indicate that Jason might express disappointment towards his son Danny Morgan (Asher Antonyzyn) for revealing Rocco Falconeri (Finn Carr)'s act of shooting Ross Cullum (Andrew Hawkes). There is a probable romantic development between Nina Reeves (Cynthia Watros) and Jack Brennan (Charles Mesure), as Nina brings Jack home to recover from his ordeal. Soap Dirt has grown to the most subscribed to YouTube soap opera channel. Visit our General Hospital section of Soap Dirt: https://soapdirt.com/category/general-hospital/ Listen to our Podcasts: https://soapdirt.podbean.com/ And Check out our always up-to-date General Hospital Spoilers page at: https://soapdirt.com/general-hospital-spoilers/ Check Out our Social Media... Twitter: https://twitter.com/SoapDirtTV Facebook: https://www.facebook.com/SoapDirt Pinterest: https://www.pinterest.com/soapdirt/ TikTok: https://www.tiktok.com/@soapdirt Instagram: https://www.instagram.com/soapdirt/

Als junge Erwachsene erfährt Nancy Wexler, dass ihre Mutter an Huntington erkrankt ist – und dass sie selbst mit 50-prozentiger Wahrscheinlichkeit dasselbe Schicksal erwartet. Ihre Reaktion: Sie wird eine der profiliertesten Forscherinnen auf diesem Gebiet.In dieser Folge sprechen wir über eine neurodegenerative Erkrankung, für die es bis heute keine Heilung gibt, und über eine Frau, die ihr Leben der Erforschung eben dieser Krankheit gewidmet hat.Es geht um Dominante Gene, Selbstfindung und „El Mal“.00:08 Huntington's Disease02:48 Keine Heilung05:50 Das falsche Protein09:45 Der Test15:28 Nancy Wexler

This week on Theme Park Thursday, Jen and Frank are heading back to Andy's room (and Toy Story Land) for a full dose of Toy Story nostalgia! They cover the movies, the rides, the land and more! Want more Toy Story? We'll be dropping a Dillo's Pop episode later today where we give our movie review for Toy Story 5! *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

This year has been partly defined by a return to M&A. In the first quarter of 2026, biopharma spent nearly $47 billion in acquisitions across 19 deals, and this week, AbbVie notched another one for the second quarter, scooping up Apogee Therapeutics and its IL-23 blocker for atopic dermatitis for around $10.9 billion. The deal follows GSK's $10.6 billion Nuvalent Bio acquisition earlier this month. These deals come as several big pharmas face patent cliffs. Sanofi, for example, will lose patent protection on Dupixent in 2031. New CEO Belén Garijo made a major play to build out Sanofi's pipeline this week, announcing that Xaira veteran Paulo Fontoura will step in as R&D chief as Houman Ashrafian exits.  Another key trend over the past 18 months has been regulatory uncertainty. This trend continues, with both uniQure and REGENXBIO announcing FDA reversals for their gene therapies for Huntington's disease and Hunter syndrome, respectively. Both companies will submit for approval of their products—a first submission for uniQure and a resubmission for REGENXBIO—in the third quarter, after the agency, under the leadership of acting commissioner Kyle Diamantas, deemed their current data sufficient. Also at the FDA, a policy memo on the agency's consideration of Sanofi's Commissioner's Priority Review Voucher for type 1 diabetes drug Tzield threw more fire on the CNPV program, which has already been mired in controversy. And the agency debuted an investigational new drug pilot program that would leverage collaborations with U.S. research institutions to reduce early trial timelines by as much as 12 months. For a special treat, we heard from BioSpace Managing Editor Jef Akst and Senior Editor Annalee Armstrong who are currently in San Diego enjoying BIO 2026. And finally, on the Eli Lilly front, a new report from Evaluate projects that the company's weight loss franchise will account for nearly half of the total sales of the top 10 drugs in 2032. But Lilly isn't resting on this envisioned success: the juggernaut is one of two companies circling Sangamo's assets as the biotech files for bankruptcy.

What does the new Justice Dept. memo really mean for people living with Huntington's Disease and their families?  We separate fact from fear in this episode.

It's Theme Park Thursday! We're discussing which Pixar IPs matter most to Disney. Frank also continues his Universal Trip Report with a full hotel and dining review! *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a rapidly evolving landscape marked by significant scientific breakthroughs, regulatory shifts, and strategic business maneuvers. The pharmaceutical and biotech sectors are buzzing with renewed vigor, as evidenced by an impressive resurgence in mergers and acquisitions. A recent analysis by PwC reports that M&A activity has reached over $65 billion in deal value during the first quarter of 2026, marking the strongest quarter since 2020. This uptick underscores a robust confidence within the industry, with companies strategically leveraging these mergers to bolster their pipelines and explore new therapeutic territories. Eli Lilly's acquisition of non-opioid pain drugmaker 4E is a case in point, as it reflects a broader industry shift towards precision medicine and non-opioid pain management solutions—a response to growing concerns over opioid addiction. On the regulatory front, notable developments include Colorado's drug import plan receiving FDA approval. This marks a bold step in curbing drug costs across the U.S., although implementation challenges remain due to complex logistical and regulatory landscapes. Meanwhile, Novo Nordisk is expanding its global manufacturing footprint with a new plant in the Czech Republic for diabetes and obesity drugs, alongside a $29 million investment to upgrade its Chinese facility. This expansion aligns with Novo's strategic preparation to seek Chinese regulatory approval for its Wegovy pill, potentially transforming the obesity treatment landscape. In a move that could reshape vaccine development, Moderna is advancing its mRNA-based influenza vaccine candidate through regulatory channels. The FDA's favorable reviews ahead of an advisory committee meeting highlight the growing acceptance of mRNA technology beyond COVID-19 vaccines. This technology holds promise for transforming vaccine development across various infectious diseases. Precision oncology continues to grapple with translating scientific discoveries into practical applications that genuinely improve patient outcomes. The ASCO 2026 conference emphasized this critical transition from discovery to implementation as essential for advancing precision medicine. Turning to gene therapy, UniQure is preparing for a significant milestone—submitting an accelerated Biologics License Application for its Huntington's disease therapy. This follows a reversal by the FDA, which now considers UniQure's Phase 1/2 trial data sufficient for submission. Should this therapy gain approval, it would be groundbreaking as the first genetic medicine for Huntington's disease, setting a precedent for future gene therapies targeting other genetic disorders. In another strategic partnership, Jazz Pharmaceuticals has teamed up with AbCellera to develop T-cell-engaging antibodies for oncology indications, illustrating the potential financial rewards associated with innovative cancer therapies. This collaboration could yield up to $820 million per program and highlights how partnerships are crucial in expediting drug development timelines. These stories reflect broader industry trends emphasizing innovation and strategic partnerships while navigating complex regulatory landscapes. The focus on precision medicine and advanced biologics continues to drive scientific advancements, with companies like Vedana Therapeutics targeting unmet needs in neurology through novel therapeutic approaches. Meanwhile, international collaboration is gaining traction in regulatory processes. The newly launched transatlantic liaison program between the FDA and MHRA aims to accelerate drug approvals and foster innovation across borders—an initiative that underscores the importance of collaborative frameworks. However, not all news is optimistic. Be Biopharma's decision to terminate its hemophilia B cell therapy trial highlights the challenges companies face in competitive therapeutic areas. Despite previous optimism, similar withdrawals by Pfizer and BioMarin indicate the necessity for robust clinical data and clear market differentiation strategies. Furthermore, Merck's recent agreement with Protillion Technologies marks an increased focus on integrating artificial intelligence into drug discovery processes—a trend promising accelerated timelines and improved trial success rates. As these developments unfold, it's evident that the pharmaceutical and biotech sectors are at an intersection where scientific innovation meets strategic business decisions. The potential approval of UniQure's gene therapy could catalyze further advancements in genetic medicine—while M&A activities suggest an industry poised for transformative growth. For stakeholders—from researchers to executives—the ability to adapt to these dynamic changes will be crucial in shaping the future of drug development and patient care. In conclusion, these stories collectively paint a picture of an industry evolving through scientific breakthroughs while adapting through strategic business decisions. As new technologies integrate into this space alongside regulatory advancements in gene therapy, this period of transformation holds promising implications for addressing unmet medical needs and enhancing therapeutic outcomes globally.Support the show

DJ Mo Radio - Mo Music. Mo Variety. In The Mix. - WPRK 91.5 Winter Park-Orlando, FL Fridays 5-7pm EST - Super Station 104.5 Huntington, WV - Mondays-Thursdays 9-11pm EST & Fridays 5-7pm EST - Website: http://www.djmoradio.com Facebook: https://www.facebook.com/djmoradio Instagram: https://www.instagram.com/djmoradio DJ Mo Booking: 407-501-6345 Email: djmoradio@gmail.com  Playlist: Jennifer Lopez Qué Hiciste (Tony Moran Radio Mix) Jennifer Lopez Naughty By Nature - Mourn You Til I Join You (Radio Edit-DJ Mo Clean Short Edit) Fat Joe - Get It Poppin' (feat. Nelly) Linkin Park - What I've Done Poison Clan - Dance All Night (Edited-DJ Mo Short Clean Edit) Stevie B. - Dreamin' Of Love Technotronic feat. Ya Kid K - Move This (Hit Mix) Flo Rida feat. Tom Martin - Do Si Do (Wait For The Drop) Afrika Bambaataa & The Soul Sonic Force - Just Get Up & Dance (Trumpet Mix) MC Hammer - 2 Legit 2 Quit (Legit Remix-DJ Mo Short Edit) The Ting Tings - Shut Up And Let Me Go (Haji & Emanuel Radio Edit) Malcolm McLaren & The Bootzilla Orchestra featuring Bootsy Collins & Introducing Lisa Marie - Something's Jumpin' In Your Shirt (feat. Bootsy Collins) [with Lisa Marie] Deadmau5 - Suckfest9001 Salt-N-Pepa - Push It (US Remix-DJ Mo Clean Edit) Bugs Bunny - Overture (Merrie Melodies Main Title Music) A Tribe Called Quest - The Space Program (Edited-DJ Mo Clean Short Edit) Main Source feat. Nas, Akinyele, & Joe Fatal - Live at the Barbecue (Refried Barbeque) Strafe - Set It Off Alien Ant Farm - Everything She wAnts Boris Dlugosch presents Booom - Keep Pushin' (DJ Mo Short Edit) Bell Biv DeVoe - When Will I See You Smile Again Lady Gaga feat. Bruno Mars - Die With A Smile (Cue's Piano Mix-Radio Edit) Martial Simon - Shake Lorde - What Was That David Guetta feat. Hypaton & Bonnie Tyler - Together (Extended) Taylor Swift - How Did It End? Barry Can't Swim - About To Begin Rihanna - Friend Of Mine (from the Smurfs Movie Soundtrack) [Radio Edit] The Prodigy - Charly (Video Version) Martin Solveig feat. Dragonette - Boys & Girls (DJ Mo Short Edit) Foster the People - Helena Beat 2 Hyped Brothers & A Dog - Doo Doo Brown (Radio Version-DJ Mo Clean edit) Don Toliver - Lose My Mind (feat. Doja Cat) The KLF feat. The First Lady Of Country Miss Tammy Wynette - Justified & Ancient (Stand By The Jams) Afrika Bambaataa & Family - Bambaataa's Theme (Assault on Precinct 13) C+C Music Factory - Gonna Make You Sweat (Everybody Dance Now) Rob Base & DJ E-Z Rock - Ready 2 Party (Hip Hop Vocal Mix) Malcolm McLaren & The Bootzilla Orchestra - Deep In Vogue (Introducing Lourdes & Willie Ninja) (DJ Mo Short Edit) Vanilla Ice - Ice Ice Baby (Edit) Beastie Boys - Brass Monkey (Edited) Steve Reece feat. Moonlight & Youkii - Wicked Game Huey Lewis & The News - The Power of Love Wayne & Garth - Wayne's World Theme (Extended Version-DJ Mo Short Edit) Ace Of Base - Beautiful Life Freestyle - In Your Face DJ Magic Mike - Feel The Bass III (DJ Mo Short Edit) Cleo Sol - Fear When You Fly Santigold - Disparate Youth Collective Soul - The World I Know Flo Rida feat. Ne-Yo - Be On You (Album Version) Pharrell Williams - Happy (From "Despicable Me 2") (Pop Edit) Jon Secada - Too Late, Too Soon Jason Derulo feat. Snoop Dogg - Wiggle (Edited) Jennifer Lopez - All I Have (feat. LL Cool J) The Black Eyed Peas - Alive (DJ Mo Short Edit) Gang Starr - Mass Appeal Girl Talk - Cleveland, Shake (DJ Mo Clean Short Edit) Gorillaz - Stylo (feat. Mos Def and Bobby Womack)

See omnystudio.com/listener for privacy information.

lick to Subscribe: https://bit.ly/Youtube-Subscribe-SoapDirt General Hospital spoilers for June 22-26, 2026 thrills as Carly Corinthos Spencer (played by Laura Wright) is put into a state of panic when a search warrant threatens to expose her and her allies. Meanwhile, Britt Westbourne (Kelly Thiebaud) finds herself in a life-threatening situation.   GH spoilers reveal Dante Falconeri (Dominic Zamprogna) and Lulu Spencer (Alexa Havins) find themselves under investigation by the villainous Colm (Andrew Hawkes), as they struggle to protect their son Rocco (Finn Carr) and Britt from his machinations. Ethan Lovett (James Ryan), trying to silence Ava Jerome (Maura West)'s blackmail threats, delivers a message while Lucas Jones (Van Hansis) finds himself in Sidwell (Carlo Rota)'s crosshairs.  Spoilers for General Hospital see the drama continues as Carly worries for her daughter Josslyn Jacks's (Eden McCoy) safety while she's ensnared at Windermere with Lisa Obrecht (Kathleen Gati). Sonny Corinthos (Maurice Benard) is determined to eliminate the threats plaguing his family. Brook Lynn Quartermaine (Amanda Setton) continues her scheme to discredit Willow Tait (Katelyn MacMullen), and Willow finds herself in a dangerous situation with Drew Cain Quartermaine (Cameron Mathison) and the scheming Brook Lynn. More GH spoilers divulge that Anna Devane (Finola Hughes) returns in the wake of the July sweeps, stepping back into her role as police commissioner. Lulu, upon learning of Rocco's call to Cassius Faison (Ryan Paevey), may take drastic action. The week ends on a cliffhanger with Britt's collapse, signaling a critical point in her battle with Huntington's disease the week of 6/22-6/26/2026. You are listening to Belynda from Soap Dirt. The most listened to podcast for soap operas. Visit our General Hospital section of Soap Dirt: https://soapdirt.com/category/general-hospital/ Listen to our Podcasts: https://soapdirt.podbean.com/ And Check out our always up-to-date General Hospital Spoilers page at: https://soapdirt.com/general-hospital-spoilers/ Check Out our Social Media... Twitter: https://twitter.com/SoapDirtTV Facebook: https://www.facebook.com/SoapDirt Pinterest: https://www.pinterest.com/soapdirt/ TikTok: https://www.tiktok.com/@soapdirt Instagram: https://www.instagram.com/soapdirt/

Full Episode on Patreon: www.patreon.com/dopeypodcast FILM FESTIVAL TICKETS: https://buytickets.at/thedopeyfoundation/2216905 Summary: This week on Dopey Tuesday, Dave sits down with Dopey Nation favorite Trinity for a hilarious, awkward, and surprisingly heartfelt conversation that serves as the setup to her deeper recovery story on Patreon. Trinity explains how she first came to the beach meeting while secretly addicted to dextromethorphan (DXM), carrying fake sober time, and trying to figure out how to get clean. She talks about discovering Dopey after seeing Dave and Handsome Evan recording at the beach and eventually becoming a fixture in Dopey Zoom and the larger Dopey community.   The conversation quickly turns into a brutally honest critique of Dopey's YouTube channel, with Trinity explaining why the audio version works so well and why the video version needs help. Along the way they discuss eye contact, recovery awkwardness, Heart Attack Doug, Dopey Zoom, listener comments, the Knicks, softball, college, selling weed in Huntington, rolling blunts, and whether Tuesdays with Doug are significantly gayer than Tuesdays with Ray.   A reading from Just For Today about resistance to change sparks a genuine conversation about fear, complacency, recovery, and the challenges of building a new life in sobriety. Dave reflects on Trinity's growth and reminds her that despite her fears she's built 227 days sober by continuing to take action and ask for help. The episode closes with Trinity performing an emotional cover of Good So Bad, the song that first connected her to Dopey and inspired her recovery journey.     Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Today on MetroNews This Morning:--It's gameday for the Mountaineers in Omaha--Capito worries a Trump appointment could derail efforts to renew FISA warrant process--Riley Moore can't say much about reports he could be in line to be the next U.S. Labor Secretary--In Sports:  The final semi-final matchups in the state HS baseball tournament are today in Huntington 

This week on Theme Park Thursday, Frank talks through his park hopping adventure from Universal Studios to Islands of Adventure, giving us the full play-by-play. We also squeeze in some Tony Awards talk and get into planning mode for a summer Disney trip. *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

What happens when you're told your dreams are impossible?When Michelle Huntington pursued aviation, she was told women shouldn't fly. One person even claimed women weren't physically suited for the cockpit.Michelle refused to accept someone else's limits.She went on to become one of fewer than 500 female airline captains worldwide, spending more than two decades making critical decisions at 35,000 feet where waiting for perfect information simply wasn't an option.Those experiences taught her a lesson that applies far beyond aviation:The greatest risk isn't being wrong. It's not deciding.Today, Michelle is a TEDx speaker, corporate trainer, and author of Lady MacGyver: Unbelievable Stories with Altitude. She helps leaders, entrepreneurs, and individuals navigate uncertainty, communicate effectively, and find calm when the pressure is on.In this inspiring conversation with Shelley Johnson and Kathy Tuccaro, Michelle shares lessons on resilience, confidence, decision-making, leadership, and trusting yourself when the path forward isn't perfectly clear.Whether you're facing a career challenge, a major life transition, or an important decision you've been putting off, this Women Road Warriors episode will encourage you to move forward with courage and clarity.https://www.michellehuntington.com/www.womenroadwarriors.comwww.womenspowernetwork.net#WomenRoadWarriors #MichelleHuntington #ShelleyJohnson #KathyTuccaro #DecisionMaking #Leadership #Confidence #Resilience #WomenInLeadership #PersonalGrowth #CareerDevelopment #CommunicationSkills #WomenEmpowerment #Mindset #LeadershipDevelopment #Aviation #FemalePilot

Today on MetroNews This Morning: --Parole denied again for a notorious Morgantown killer--Two United Way groups in West Virginia team up ahead of the next natural disaster --An acid mine treatment facility has cleaned up a Monongalia County stream.--In Sports: the state baseball tournament is moving in Huntington and WVU now knows the schedule for the CWS in Omaha 

Frank just got back from his very first trip to Epic Universe and we're breaking it all down: the portals, the rides, the food, the vibes, and whether or not the expectations were dillo'ed. *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

May 31, 2026: They say the fires at Caledonia Mills started on their own, but anyone who spent a night there knew something far more sinister was at work.==========HOUR ONE: “The Witching Hour of 3AM” *** You don't have to go to a cemetery or haunted house to experience the supernatural. You don't need to drive a cursed road to encounter a ghost. Sometimes the paranormal takes place on military bases. (The Military And The Mysterious) *** The corpse of a murderer winds up doing advertising for a drug store. (The Murder of Maggie Walker) *** In 1922, an otherwise unremarkable farmhouse in Novia Scotia was the site of alleged poltergeist activity which made headlines all over Canada and the United States. A poltergeist that liked to set fires. (The Fire Spook of Caledonia Mills)==========HOUR TWO: Claiming to audibly hear from God either makes you crazy, or a prophet – and only time can tell which is true. If you claim things are going to happen because God says they will – and then they don't happen – that means you're cray cray, and a false prophet. That also makes your followers a bunch of dupes. Sadly, the 19th and 20th centuries were full of crazy false prophets with mindless sheep worshipping them. (Creating False Prophets) *** Headline: “Exciting Wake!” When you see the words “exciting” and “wake” in the same headline, you can make a guess that someone is not resting in peace! (Exciting Wake)==========SUDDEN DEATH OVERTIME: A smitten fan falls in love with a talented actress, and convinces himself she loves him in return. This sounds very much like a story out of today's entertainment magazines – but this tale of unrequited love took place in the 1880's. (The Lunatic James Dougherty) *** The terrifying Aswang is the most feared creature of Philippine folklore—and with good reason. I'll tell you why. (The Deadly Aswang) ** Reports have been coming in from people claiming to see full-sized African lions not in the Savannah or in the wilderness – but in North America. But is there any truth to the their claims? (Phantom Lions of North America)==========SOURCES AND REFERENCES FROM TONIGHT'S SHOW:BOOK: “Mysterious America” by Loren Coleman: https://amzn.to/3lZIviBBOOK: “Creatures of Philippine Lower Mythology”: https://amzn.to/3m2Re3kDOCUMENTARY: “The Aswang Phenomenon”: https://amzn.to/3jQrNjC“Creating False Prophets” by Dr. Romeo Vitelli for Providentia: https://tinyurl.com/y5bqt97p,https://tinyurl.com/y26vpmga, https://tinyurl.com/y6tgpcl3, https://tinyurl.com/y2jy3eqf“Phantom Lions of North America” by Brent Swancer for MysteriousUniverse.com: https://tinyurl.com/yygdg3eh“Exciting Wake” from the Huntington, IN “Daily Democrat”, reposted on the Strange Company website: https://tinyurl.com/y5cy4ksa“The Deadly Aswang” by Professor Geller for Mythology.net: https://tinyurl.com/yxhcrcxc“The Witching Hour of 3AM” from Paranormality Magazine“The Fire Spook of Caledonia Mills” by Hammerson Peters for MysteriesOfCanada.com: https://tinyurl.com/y43ug999“The Lunatic James Dougherty” by Robert Wilhelm for MurderByGaslight.com: https://tinyurl.com/yxkxo8b6“The Military and the Mysterious” by Brent Swancer for MysteriousUniverse.org: https://tinyurl.com/y46jdmks“The Murder of Maggie Walker” posted on the website Murders In History: https://tinyurl.com/y2qw2rup==========Join the Weird Darkness Syndicate: https://weirddarkness.com//syndicateWeird Darkness theme by Alibi Music Library. Background music provided by Alibi Music Library, EpidemicSound and/or StoryBlocks with paid license. Music from Shadows Symphony (https://tinyurl.com/yyrv987t), Midnight Syndicate (http://amzn.to/2BYCoXZ) Kevin MacLeod (https://tinyurl.com/y2v7fgbu), Tony Longworth (https://tinyurl.com/y2nhnbt7), and Nicolas Gasparini (https://tinyurl.com/lnqpfs8) is used with permission of the artists.==========PODCASTS I HOST:Weird Darkness: https://weirddarkness.com/listenParanormality Magazine: https://weirddarkness.tiny.us/paranormalitymagMicro Terrors: Scary Stories for Kids: https://weirddarkness.tiny.us/microterrorsRetro Radio – Old Time Radio In The Dark: https://weirddarkness.tiny.us/retroradioChurch of the Undead: https://weirddarkness.tiny.us/churchoftheundead==========(Over time links seen above may become invalid, disappear, or have different content. I always make sure to give authors credit for the material I use whenever possible. If I somehow overlooked doing so for a story, or if a credit is incorrect, please let me know and I will rectify it in these show notes immediately. Some links included above may benefit me financially through qualifying purchases.)=========="I have come into the world as a light, so that no one who believes in me should stay in darkness." — John 12:46==========WeirdDarkness® is a registered trademark. Copyright ©2026, Weird Darkness.==========

What does it cost to give your life away quietly?In this month's Velvet Ashes Legacy Podcast, Sarah sits down with author Jordan Monson to explore the remarkable story of Katharine “Katy” Barnwell—a woman whose influence on Bible translation shaped millions of lives, even though most people have never heard her name.Born in London during the Blitz, Katie's story begins in the shadow of war and unfolds into a lifetime of faithful, behind-the-scenes service. From learning unwritten languages in Nigeria to helping transform Bible translation into a model that empowered local believers, Katy carried a vision that changed the global church.But her story is also one of cost.The cost of singleness.The cost of obscurity.The cost of staying through hardship, civil war, exhaustion, and years far from home.The cost of offering your gifts fully to God without needing recognition in return.This conversation is a reminder that God has always used ordinary, imperfect people to do extraordinary things.Jordan Monson is an author and the Professor of Missions and Old Testament at Huntington University. He also directs Huntington's Center for Faith Integration and Vocation. Learn more about ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Velvet Ashes⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Velvet Ashes on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Featured music is "Doxology of Mercy" by Eine Blume. Check out more from them on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠iTunes⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or wherever you get music!We are grateful to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Barnabas International⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for sponsoring this podcast! Barnabas is a member care organization that shepherds global workers and trains global shepherds. Learn more about them ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Learn more about our Online Retreat for this year, ⁠Listen: Hear My Voice⁠Check out Jordan's book, Katharine Barnwell: How One Woman Revolutionized Modern MissionsThe new Velvet Ashes book, Yet We Still Laugh, is available on ⁠⁠⁠⁠Amazon⁠⁠⁠⁠ and ⁠⁠⁠⁠Barnes & Noble

Frank may have had the week off, but the party didn't stop! Jen sits down with Louis and Val to relive their unforgettable experiences at the Magic Kingdom and Hollywood Studios After Parties. *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

Show Notes: Peter Schmidt talks about his senior year during the Iraq War, and how the news on the problem of jobless recovery led him to consider graduate school.  The Journey from Student to Dean Peter studied biomechanics at Cornell, focusing on the mathematics of biological systems and modeling clinical trials in orthopedics. He was admitted into  a fellowship program in New York at an orthopedic  hospital where he worked on total joint replacement.  His career path led him to neuroscience, where he led clinical research and worked for a nonprofit before becoming the vice dean of a medical school. He then moved on to running clinical trials and drug development.  A Focus on Parkinson's Disease Pete shares his interest in Parkinson's disease and explains that Parkinson's affects a tractable part of the brain, the basal ganglia, which is easier to model mathematically. He enjoys thinking about neuronal signaling and the microstructure of the brain, which helps in understanding the macro structure. Pete's PhD work involved modeling bone at the cellular level, and he applies similar thinking to the basal ganglia in Parkinson's disease. Research on Neurodegenerative Diseases Pete discusses the challenges in determining whether a question in neurodegenerative diseases is a question of science or engineering. He explains the historical focus on stem cells and extracellular proteins as solutions for diseases like Alzheimer's and Parkinson's. Pete emphasizes the need to understand the role of extracellular proteins and the importance of scientific inquiry. He mentions the Nobel Prize-winning discovery of prion diseases and the subsequent focus on characteristic proteins in neurodegenerative diseases, which led to initiatives focused on proteins.  The Brain's Micro and Macro Structures Pete discusses the current focus on extracellular proteins and the challenges in proving their role in diseases like Parkinson's. He mentions the drug Lecanemab for Alzheimer's, which slows the disease but does not reverse it. Pete predicts that future research will focus on intracellular proteins and the need to restore lost cells in the brain. He highlights the importance of understanding the microstructure to inform the macro structure of the brain. The Logistics of Running Clinical Trials Pete explains that success in clinical trials is more about logistics than science, with 90-95% of the work being logistical. He discusses the challenges of recruiting subjects and the importance of working with academic medical centers that have a high volume of patients. Pete emphasizes the need for fast-moving ethics boards and efficient contracting to ensure the success of clinical trials. Incentives for Physicians When asked about the incentives for physicians to participate in clinical trials, Pete explains that most physicians are driven by scientific interest rather than financial incentives. He mentions the importance of academic leaders who can influence the participation of residents and fellows in trials. Pete highlights the passion of physicians in diseases like Huntington's and cystic fibrosis, which drives their engagement in research. The Role of Pharma Companies in Clinical Trials Pete talks about his role at East Carolina University where he oversaw clinical care and research at the medical school. He discusses the changing role of pharma companies in running clinical trials. He explains that many drugs are now discovered in labs, leading to a shift in the need for pharma companies to own their data. Pete mentions the issue of trial fraud, where fake patients are used to inflate data, and the importance of tighter control over trial data. He shares his experience of rescuing a trial from fraudulent data and the challenges of identifying such issues. Life on the Family Farm The conversation turns to Pete's family life, and Pete shares that his youngest child recently went to college, and he inherited a family farm that has been in his wife's family for 200 years. He enjoys working with his hands, doing woodworking, and using a skid steer for various tasks on the farm. Pete describes his role as the farm handyman, fixing things and maintaining the farm equipment. Harvard Reflections Pete mentions taking a quantum mechanics course and a material science class with X-ray interferometry. He highlights the impact of a physics class on fits and tolerances, which taught him about the importance of clearance and interference fits. Pete also shares his experience taking a folklore course with his roommate, which was his only pass/fail course at Harvard.  Pete explains the concept of fits and tolerances in engineering. He discusses the importance of understanding whether a fit needs to be tight or loose and planning accordingly. Pete uses examples from finance to illustrate the principle of having a cushion in budgeting. He emphasizes the need to know the target fit (tight or loose) to optimize engineering and design solutions. This episode on The 92 Report:https://92report.com/podcast/168-peter-schmidt-from-math-to-neuroscience/ Timestamps: 02:40: A focus on Parkinson's Disease  05:10: Challenges in Neurodegenerative Disease Research 09:50: The Role of Extracellular Proteins and Future Directions  17:34: Running Clinical Trials and Logistics  27:58: Incentives for Physicians to Participate in Clinical Trials  32:16: Pharma Companies and Clinical Trial Data  38:53: Personal Life and Farming  42:30: Reflections on Harvard Courses 46:23: Fits and Tolerances in Engineering  Links: https://www.linkedin.com/in/pnschmidt https://www.instagram.com/pnschmidt  

Actor and “SNL” alum Will Forte joins Rob Lowe to discuss the release of the long-awaited “Coyote vs. Acme” movie, their animated “Miami Vice” parody from years ago, and the advice they have received from acting greats. Will also shares why raising awareness for Huntington's disease is a cause close to his heart. Plus, stay tuned for a special surprise cameo. To find out more about Huntington's disease, visit www.honestlyhd.com. Make sure to subscribe to the show on YouTube at YouTube.com/@LiterallyWithRobLowe! Got a question for Rob? Call our voicemail at 323-570-4551. Your question could get featured on the show! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week on Theme Park Thursday, Jen and Frank talk about the latest Disney park news and updates. PLUS, one of them has an epic trip on the horizon! *** Learn more about our Dillo's Discord Universe here: https://www.patreon.com/posts/dillos-discord-150502505 ***

Welcome back to SANDCAST: Beach Volleyball with Tri Bourne and Travis Mewhirter, where Travis is talking a big weekend with the AVP debuting its Heritage events in Huntington Beach and plenty to talk about there, and the Beach Pro Tour continuing its season at the Xiamen Challenge, where AK and Alexis stayed PERFECT with another gold medal. We're chatting: Savvy Cory and Evan Cory having the biggest family weekend ever Thamela and Victoria putting on a show at AVP Huntington Beach Taylor Crabb and Andy Benesh establishing themselves as the best team in America with their win Audrey Koenig and Alexis Durish staying perfect with ANOTHER gold medal in China, now riding a 44 match win streak And a whole lot more! SHOOTS! We have a NEW BOOK! Pre-order your copy of Volleyball for Dummies today at Barnes and Noble! Want SANDCAST merch? We got you covered. Check it out here! Get 25 PERCENT off all Mikasa products with our code, SANDCAST and play with the ball. played with the best in the game. Head to Mikasa's website and get your bag of balls today! Get 10 PERCENT OFF VBTV using our discount code, SANDCAST10 Want to get better at beach volleyball? Use our discount code, SANDCAST, and get 10 percent off all Better at Beach products!  If you want to receive our SANDCAST weekly newsletter, the Beach Volleyball Digest, which dishes all the biggest news in beach volleyball in one quick newsletter, click here and sign on up! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week on the Long Island Tea Podcast, Sharon and Stacy are fully embracing the spirit of Memorial Day Weekend and all the national celebrations happening across Long Island — from Memorial Day to National Wine Day, National Maritime Day, National Craft Distillery Day, and so much more! The ladies kick things off by recapping some exciting recent events they attended including the Latino Business Awards, downtown revitalization announcements, and other exciting happenings across the region. Plus, after patiently waiting, they're finally cracking open their custom RGNY vintage to celebrate on-air! Between the laughs, local stories, summer energy, and one absolutely hysterical impression from Stacy that you truly do not want to miss, this episode perfectly captures everything we love about Long Island this time of year.#ShowUsYourLongIslanderThis week we're spotlighting Chris R. Vaccaro, who was recently honored with the Suffolk County Sheriff's Community Leadership Award for his decades of impact across education, journalism, sports history, and community service.#RevolutionaryRootsThis week we're visiting North End Burial Ground in Southampton, a historic Revolutionary War era site honoring local patriots and soldiers connected to Long Island's colonial history.#LongIslandLifeJones Beach is preparing for America's 250th anniversary celebration with a massive Fourth of July weekend event featuring live music, reenactments, and a drone show.We're also reflecting on Mental Health Awareness Month and the many peaceful places across Long Island that help people recharge and reconnect.The United States Postal Service is encouraging homeowners to participate in Mailbox Improvement Week by making sure mailboxes are safe and accessible for postal workers.The Whaling Museum & Education Center of Cold Spring Harbor is launching a public naming contest for its new inflatable sperm whale ahead of World Ocean Day.Blue Point Brewing has officially launched Magic Hour IPA, a new tropical inspired summer beer perfect for Long Island sunsets.iVogue Couture in Huntington is creating a unique blend of fashion, entrepreneurship, and community through custom designs and networking tea gatherings.Montauk was ranked the second best fishing destination in the country for Memorial Day Weekend 2026.We're celebrating National Maritime Day by spotlighting Long Island's deep connection to waterfront history and local maritime museums.National Craft Distillery Day is also shining a spotlight on Long Island favorites like Twisted Cow Distillery and Spy Trail Distillery.Long Island Wine Country is kicking off another season of brunches, tastings, and vineyard weekends ahead of National Wine Day.Splish Splash Water Park officially opens for its 36th season with Neon Nights, Kids Fest, and exciting new additions for summer 2026.Stony Brook University will host Long Island's official FIFA World Cup watch party this June with outdoor screenings, entertainment, and family fun.Long Island's official 2026 History Hunt challenge launches this weekend, inviting visitors to explore 26 historic sites stretching from Brooklyn to Montauk.#ThisWeekendOnLongIslandThis weekend features everything from concerts and theater performances to farmers markets, vineyard brunches, and live music across Long Island.#CelebriTEATate's Bake Shop cookies were featured on the latest season of HBO's Hacks, giving another exciting spotlight to the iconic Southampton brand.Michael Kors is making headlines after listing his Fire Island retreat for $6.3 million.#hotTEAsCall 877-386-6654 x 400, leave us a review, and send us a screenshot to score $5 off merch while staying connected with all things Long Island Tea.Connect With UsInstagram: @longislandteapodcastTikTok: @longislandteapodcastYouTube: Discover Long Island YouTubeFacebook: Long Island Tea Podcast FacebookX: @liteapodcastEmail: spillthetea@discoverlongisland.comShop: Discover Long Island Shop Hosted on Acast. See acast.com/privacy for more information.

Discover the incredible story of Cecelia Castaneda, who faced Huntington's disease head-on and experienced a transformation few thought possible. In this exclusive interview, Cecelia shares how she went from relying on a wheelchair to walking and living a normal life, defying all expectations. Find out what sparked this dramatic neurological recovery and what it could mean for the future of Huntington's patients. Don't miss the inspiring journey behind her reversal. Listen to uncover the details! YouTube: https://www.youtube.com/@GeneticCanary Instagram: https://www.instagram.com/tarotofthe9s/   Join my NEW 90-day Carnivore Challenge group on Mighty Networks below! https://dr-chaffee-s-90-day-carnivore-challenge.mn.co/landing/ If you liked this and want to learn more go to my new website www.DrAnthonyChaffee.com

Dr. Laura Bradfield is Senior Lecturer in the School of Psychology at The University of Sydney. In the lab, Laura studies the behavioral and brain mechanisms of compulsivity and compulsive disorders. Conditions like obsessive compulsive disorder, substance use disorder, Parkinson's disease, and Huntington's disease all have elements of compulsivity. Rather than focusing on one particular condition, Laura and her team are working on developing better animal models of compulsivity and understanding how inflammation in certain parts of the brain affects compulsive behaviors. Outside of research, Laura loves to sing, and she enjoys going out for karaoke with colleagues in the evenings during conferences. She is also a fan of CrossFit workouts and spending time with her 14-year-old daughter. Laura received her bachelor's degree with honors in psychology and her PhD in neuroscience from the University of New South Wales, Sydney. She conducted postdoctoral research at the University of Sydney and subsequently the University of New South Wales. Prior to joining the faculty at The University of Sydney, Laura served as a Lecturer at University of New South Wales and a Research Fellow and Senior Research Fellow at the University of Technology Sydney. In this interview, she shares more about her life and science. 

Survivor 50 B&B Ep 11 Recap w/ Justin McElroy With a new Survivor season upon us, it's time for Mike Bloom and Liana Boraas to re-open the RHAP B&B! On the B&B, Mike and Liana are inspired by the lighter side of Survivor, featuring a series of segments and games based on what's happening on Survivor that week.  This week, Mike and Liana are joined by legendary podcaster Justin McElroy for Episode 11! Get ready for a jam-packed Survivor 50 double boot breakdown as Mike Bloom and Liana Boraas welcome renowned podcaster and guest Justin McElroy to the RHAP B&B! With just two episodes left before the finale, the trio celebrates Mother’s Day and dives straight into one of the wildest nights yet where legends fall, idols stay hidden, and historic moves shake up the game. The conversation zeroes in on the latest double elimination, where Ozzy, the living legend, is sent home with an idol in his pocket while another Survivor icon, Cirie, pulls off an epic power play using the only advantage she's held all season. The hosts and Justin dissect how the constant twists, like the Mr. Beast coin flip and group splits, have cranked up the chaos and blurred traditional alliance lines. They share why this season's cast is maybe the most stacked in Survivor history and debate whether all the added advantages are crowding out pure gameplay. Key moments include: – Justin McElroy's take on why the Survivor 50 cast is legendary but might be over-twisted – The downfall of Ozzy: idol misplays, misguided trust, and repeated Survivor mistakes – Cirie's calm brilliance, pulling strings behind the scenes and making alliances feel safe – The break-up of big groups and the lack of clear alliances as the game barrels toward the final seven – Emily Flippin's exit with her reputation for spilling secrets, social bonds, and how Cirie's extra vote sealed her fate How will players adapt with legends like Ozzy gone and Cirie asserting control? With alliances uncertain and the finish line in sight, every vote and advantage could mean the difference between fire-making glory and heartbreak. Don't miss this candid, insightful, and funny Survivor 50 B&B as the crew questions who will survive the shifting sands of strategy and who's in prime position to win it all! 0:00 Epic Double Boot: Ozzy Blindsided 5:32 Breaking Down the Split Tribe Twist 10:16 Ozzy's Idol Mistake and Exit 20:17 Emily Flippin's Big Move Fails 23:38 Rick Devens' Showmanship Examined 26:10 Cirie's Ice-Cold Strategic Mastery 31:41 Preseason Predictions: Emily Flippin 36:07 Preseason Predictions: Ozzy's Game 41:26 Challenge Beasts and the “Beefy Boys” 50:36 Impact of Double Elimination Episodes 54:24 Before and After: Survivor 50 Game 1:07:25 Survivor 50 Winner Pick and Finale Wishes This week's charity shoutout is Harmony House, an organization seeking to end homelessness in the Huntington area through permanent housing and supportive service programs. Click here to make a donation. (https://harmonyhousewv.networkforgood.com/projects/37203-harmony-housem?) If you have any suggestions for games or feedback for the B&B, feel free to reach out to us on social media or email rhapbnb [at] gmail [dot] com. To pre-order Rob's book, The Tribe and I Have Spoken, visit www.robhasabook.com Never miss a minute of RHAP's extensive Survivor coverage! LISTEN: Subscribe to the Survivor podcast feed WATCH:  Watch and subscribe to the podcast on YouTube SUPPORT:  Become a RHAP Patron for bonus content, access to Facebook and Discord groups plus more great perks!

Survivor 50 B&B Ep 11 Recap w/ Justin McElroy With a new Survivor season upon us, it's time for Mike Bloom and Liana Boraas to re-open the RHAP B&B! On the B&B, Mike and Liana are inspired by the lighter side of Survivor, featuring a series of segments and games based on what's happening on Survivor that week.  This week, Mike and Liana are joined by legendary podcaster Justin McElroy for Episode 11! Get ready for a jam-packed Survivor 50 double boot breakdown as Mike Bloom and Liana Boraas welcome renowned podcaster and guest Justin McElroy to the RHAP B&B! With just two episodes left before the finale, the trio celebrates Mother’s Day and dives straight into one of the wildest nights yet where legends fall, idols stay hidden, and historic moves shake up the game. The conversation zeroes in on the latest double elimination, where Ozzy, the living legend, is sent home with an idol in his pocket while another Survivor icon, Cirie, pulls off an epic power play using the only advantage she's held all season. The hosts and Justin dissect how the constant twists, like the Mr. Beast coin flip and group splits, have cranked up the chaos and blurred traditional alliance lines. They share why this season's cast is maybe the most stacked in Survivor history and debate whether all the added advantages are crowding out pure gameplay. Key moments include: – Justin McElroy's take on why the Survivor 50 cast is legendary but might be over-twisted – The downfall of Ozzy: idol misplays, misguided trust, and repeated Survivor mistakes – Cirie's calm brilliance, pulling strings behind the scenes and making alliances feel safe – The break-up of big groups and the lack of clear alliances as the game barrels toward the final seven – Emily Flippin's exit with her reputation for spilling secrets, social bonds, and how Cirie's extra vote sealed her fate How will players adapt with legends like Ozzy gone and Cirie asserting control? With alliances uncertain and the finish line in sight, every vote and advantage could mean the difference between fire-making glory and heartbreak. Don't miss this candid, insightful, and funny Survivor 50 B&B as the crew questions who will survive the shifting sands of strategy and who's in prime position to win it all! 0:00 Epic Double Boot: Ozzy Blindsided 5:32 Breaking Down the Split Tribe Twist 10:16 Ozzy's Idol Mistake and Exit 20:17 Emily Flippin's Big Move Fails 23:38 Rick Devens' Showmanship Examined 26:10 Cirie's Ice-Cold Strategic Mastery 31:41 Preseason Predictions: Emily Flippin 36:07 Preseason Predictions: Ozzy's Game 41:26 Challenge Beasts and the “Beefy Boys” 50:36 Impact of Double Elimination Episodes 54:24 Before and After: Survivor 50 Game 1:07:25 Survivor 50 Winner Pick and Finale Wishes This week's charity shoutout is Harmony House, an organization seeking to end homelessness in the Huntington area through permanent housing and supportive service programs. Click here to make a donation. (https://harmonyhousewv.networkforgood.com/projects/37203-harmony-housem?) If you have any suggestions for games or feedback for the B&B, feel free to reach out to us on social media or email rhapbnb [at] gmail [dot] com. To pre-order Rob's book, The Tribe and I Have Spoken, visit www.robhasabook.com Never miss a minute of RHAP's extensive Survivor coverage! LISTEN: Subscribe to the Survivor podcast feed WATCH:  Watch and subscribe to the podcast on YouTube SUPPORT:  Become a RHAP Patron for bonus content, access to Facebook and Discord groups plus more great perks!